Crystal Lake, Illinois Clinical Trials

A listing of Crystal Lake, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 8 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

solid tumors
monoclonal antibodies
adjuvant therapy
liver metastasis
AMG Crystal Lake - Oncology
 (2.5 away) Contact site
  • 27 Jul, 2021
  • +978 other locations
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

replacement therapy
serum testosterone
testosterone topical
testosterone level
Midwest Endocrinology /ID# 202992
 (0.6 away) Contact site
  • 30 Jul, 2021
  • +485 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

skin cancer
systemic therapy
heart failure
cutaneous squamous cell carcinoma
North Shore Oncology Hematology Associates-Crystal Lake
 (2.5 away) Contact site
  • 01 Aug, 2021
  • +1020 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

absolute neutrophil count
anaphylactic reactions
monoclonal antibody therapy
monoclonal antibodies
AMG Crystal Lake - Oncology
 (2.5 away) Contact site
  • 01 Aug, 2021
  • +589 other locations
A Randomized Double-Blind Parallel Group Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

Study STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

acute treatment
CIS Research
 (9.3 away) Contact site
  • 02 Aug, 2021
  • +139 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

brain metastases
monoclonal antibodies
leptomeningeal disease
cancer treatment
AMG Crystal Lake - Oncology
 (2.3 away) Contact site
  • 01 Aug, 2021
  • +831 other locations
Efficacy and Safety of LX9211 in Patients With Postherpetic Neuralgia

Evaluation of the efficacy of LX9211 compared to placebo in reducing pain related to postherpetic neuralgia over an 11 week assessment period.

Lexicon Investigational Site
 (9.3 away) Contact site
  • 28 Jul, 2021
  • +21 other locations
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

To demonstrate the efficacy of VERU-111 (Sabizabulin) in the treatment of metastatic castration-resistant prostate cancer in patients who have failed prior treatment with at least one androgen receptor targeting agent as measured by radiographic progression-free survival.

Comprehensive Urologic Care
 (8.7 away) Contact site
  • 01 Aug, 2021
  • +37 other locations